CCR 20th Anniversary Commentary: Chimeric Antigen Receptors-From Model T to the Tesla.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 26180056.
- Also identified by DOI 10.1158/1078-0432.CCR-14-2560.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The research article by Kershaw and colleagues, published in the October 15, 2006, issue of Clinical Cancer Research, presents one of the first clinical trials to utilize chimeric antigen receptors. Subsequent studies have shown promise for the treatment of patients with lymphoid malignancies, but further progress will require optimization, including the identification of more specific antigens for solid tumors.
Medical subject headings
- Immunotherapy
- Neoplasms
- Receptors, Antigen